Rontalizumab

• CAT Number: I042440
• CAS Number: 948570-30-7
• Molecular Weight: 145.9 (kDa)
• Purity: ≥95%

Rontalizumab is a humanized IgG1 monoclonal antibody targets IFN-α. Rontalizumab can be used for the research of systemic lupus erythematosus[1].

Reference

[1]. McBride JM, et al. Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. Arthritis Rheum. 2012 Nov;64(11):3666-76.
 [Content Brief]